Canada High Court OKs Ban On Pharmacy-Brand Generics

Law360, New York (November 22, 2013, 7:01 PM EST) -- The Supreme Court of Canada ruled Friday that two drug stores in Ontario may not designate their own brand of generic drugs as “interchangeable” with the name-brand versions because it could lead to pharmacies sharing in the revenues of drug manufacturers.

Sanis Health Inc., a subsidiary of Shoppers Drug Mart Corp., was formed for the purpose of buying generic drugs from third-party fabricators and selling the drugs under the Sanis label in Shoppers Drug Mart stores, the court said. Katz Group Canada Inc., Pharma Plus Drug...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.